Cargando…

BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer's disease

Because of a lack of sensitive biomarkers, the diagnosis of Alzheimer's disease (AD) cannot be made prior to symptom manifestation. Therefore, it is crucial to identify novel biomarkers for the presymptomatic diagnosis of AD. While brain lesions are a major feature of AD, retinal pathological c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lan, Luo, Jia, Chen, Dan, Tong, Jian-bin, Zeng, Le-ping, Cao, Yan-qun, Xiang, Jian, Luo, Xue-gang, Shi, Jing-ming, Wang, Hui, Huang, Ju-fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829010/ https://www.ncbi.nlm.nih.gov/pubmed/27127484 http://dx.doi.org/10.4103/1673-5374.179057

Ejemplares similares

BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer’s disease
por: Bao, Jian, et al.
Publicado: (2018)

Synaptophysin Expression in Rat Retina Following Acute High Intraocular Pressure
por: Dan, Chen, et al.
Publicado: (2008)

BACE1: from biomarker to Alzheimer’s disease therapeutical target
por: Cervellati, Carlo, et al.
Publicado: (2021)

Timosaponin-BII inhibits the up-regulation of BACE1 induced by Ferric Chloride in rat retina
por: Huang, Ju-Fang, et al.
Publicado: (2012)

PS1 Affects the Pathology of Alzheimer’s Disease by Regulating BACE1 Distribution in the ER and BACE1 Maturation in the Golgi Apparatus
por: Li, Nuomin, et al.
Publicado: (2022)

Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
por: Decourt, Boris, et al.
Publicado: (2013)

BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology
por: Koelsch, Gerald
Publicado: (2017)

ARL6IP1 mediates small-molecule-induced alleviation of Alzheimer pathology through FXR1-dependent BACE1 translation initiation
por: Zhou, Gui-Feng, et al.
Publicado: (2023)

Role of BACE1 in Alzheimer’s synaptic function
por: Das, Brati, et al.
Publicado: (2017)

AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model
por: Marino, Marika, et al.
Publicado: (2022)

The Alzheimer's disease β-secretase enzyme, BACE1
por: Cole, Sarah L, et al.
Publicado: (2007)

Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
por: Coimbra, Judite R. M., et al.
Publicado: (2018)

Post-Translational Modifications of BACE1 in Alzheimer's Disease
por: Wen, Wen, et al.
Publicado: (2022)

Adipose mesenchymal stem cell-derived extracellular vesicles reduce glutamate-induced excitotoxicity in the retina
por: Duan, Tian-Qi, et al.
Publicado: (2023)

Triptolide treatment reduces Alzheimer’s disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD
por: Wang, Qi, et al.
Publicado: (2014)

Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease
por: Feng, Liang, et al.
Publicado: (2018)

BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2012)

BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2013)

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
por: Vassar, Robert
Publicado: (2014)

BACE1 inhibition as a therapeutic strategy for Alzheimer's disease
por: Vassar, Robert
Publicado: (2016)

BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
por: Maia, Miguel A., et al.
Publicado: (2019)

BACE2: A Promising Neuroprotective Candidate for Alzheimer’s Disease
por: Yeap, Yee Jie, et al.
Publicado: (2023)

The Retina in Alzheimer's Disease: Histomorphometric Analysis of an Ophthalmologic Biomarker
por: Asanad, Samuel, et al.
Publicado: (2019)

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
por: Alić, Ivan, et al.
Publicado: (2020)

BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer’s Disease Markers in Elderly Healthy Participants
por: Timmers, Maarten, et al.
Publicado: (2017)

Prognosis of Biomarker of Alzheimer's Disease in the Function of the Retina and Secondary Molecular Structure Variation of the Retina and Brain
por: Gaber, Heba Ahmed, et al.
Publicado: (2023)

Rescue of Early bace-1 and Global DNA Demethylation by S-Adenosylmethionine Reduces Amyloid Pathology and Improves Cognition in an Alzheimer’s Model
por: Do Carmo, Sonia, et al.
Publicado: (2016)

BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
por: Sjölander, Annica, et al.
Publicado: (2010)

Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
por: Alić, Ivan, et al.
Publicado: (2021)

The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
por: Neumann, Ulf, et al.
Publicado: (2018)

BACE1 Inhibitors for Alzheimer’s Disease: The Past, Present and Any Future?
por: Bazzari, Firas H., et al.
Publicado: (2022)

Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1-AS expression
por: LIU, TE, et al.
Publicado: (2014)

Functional insights from targeted imaging BACE1: the first near-infrared fluorescent probe for Alzheimer’s disease diagnosis
por: Bi, Anyao, et al.
Publicado: (2022)

The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer’s Disease
por: Cole, S.L, et al.
Publicado: (2007)

Sorting out the cell biology of Alzheimer’s disease: focus on BACE1 and APP
por: Annaert, Wim
Publicado: (2012)

Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease
por: Grimmer, Timo, et al.
Publicado: (2012)

The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease
por: Vassar, Robert, et al.
Publicado: (2011)

In Silico Design of BACE1 Inhibitor for Alzheimer's Disease by Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
por: Yan, Riqiang
Publicado: (2016)

Functions of the Alzheimer’s Disease Protease BACE1 at the Synapse in the Central Nervous System
por: Munro, Kathryn M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q68jkus1lqc0ujd99n4srjmq2a